Studies show that demographic differences can impact cancer care and that disadvantaged populations suffer from a lack of access to advanced precision cancer diagnostics and treatments. Evaluating and … [Read more...]
DX Deals
Labcorp Teams with Oncology Research Startup to Eliminate Demographic Disparities in Cancer Treatment
September 13, 2021
DX Deals
Cloud-Based Platform Enlists Quest to Provide COVID-19 Molecular Test Results to Travelers
August 16, 2021
As proof of COVID-19 vaccination and/or negative molecular test results morphs into a passport for air travel and attending live events, labs with the capacity to generate rapid and reliable tests and … [Read more...]
DX Deals
Amazon Already Making a Mark on Direct-to-Consumer COVID-19 Test Market
July 11, 2021
Will Amazon transform diagnostic lab testing the way it did the retail industry? Probably not. But the tech giant with the proven capacity to reach into the home and change the shopping patterns of … [Read more...]
DX Deals
Labs Cutting Deals to Provide Pooled COVID-19 Testing for Schools
June 14, 2021
As schools return to in-person learning environments, communities across the country are turning to COVID-19 testing programs to monitor and contain the virus. Although, more and more teachers, … [Read more...]
DX Deals
Eurofins Teams with Uber for Home Delivery of COVID-19 Test Kits
May 19, 2021
At-home COVID-19 testing and sample collection is becoming so big that it’s drawing players from outside the lab testing market. And it’s not just the Walgreens, Walmarts, Amazons and other retailers … [Read more...]
DX Deals
Hologic Leverages Google Cloud Machine Learning to Boost Cervical Cancer Screening
March 5, 2021
Hologic has its head in a cloud. And that’s a good thing. On Feb. 1, the Massachusetts-based medical technology firm announced that it has entered into a strategic collaboration with Google Cloud to … [Read more...]
DX Deals
Siemens, California Health Network and Biopharm Research Company Partner for Enhanced Liver Fibrosis Testing
January 10, 2021
Although COVID-19 remains the driving force, non-pandemic-related strategic deal making continues. Among the most impactful deals announced in December is the partnership among Renown Institute for … [Read more...]
DX Earnings Report
Q3 Creates the Perfect Storm of Sustained COVID-19 Tailwinds and Diminishing Headwinds
December 2, 2020
July through September 2020 was a remarkable quarter for most diagnostics firms. In fact, it was the closest thing to a perfect storm for earnings. Pandemic tailwinds drove massive revenues for firms … [Read more...]
Diagnostic Deals
Labs, Universities and Even Computer Companies Target Point-of-Care COVID-19 Test Development
April 1, 2020
The imperative to create and provide tests capable of detecting the SARS-CoV-2 virus that causes COVID-19 coronavirus continues to fuel strategic deal making. SARS-CoV-2 point-of-care tests was the … [Read more...]
DIAGNOSTIC DEALS
Diagnostic Deals: Urgent Need for Coronavirus Diagnostics Fuels Strategic Collaboration
March 1, 2020
Not surprisingly, teaming up for development and commercialization of coronavirus (COVID-19) detection and vaccination products was a major theme of strategic alliance making during the period. … [Read more...]
